For the first time ever ECCMID will take place as a hybrid event, both onsite and online.
Make yourself familiar with the latest product launches and diagnostic solutions Bruker offers to resolve healthcare challenges.
We will be discussing our latest developments at the show, highlighting:
Chair: Dr. Belén Rodríguez Sánchez, Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital Gregorio Marañón, Madrid, Spain
Chair: Prof. Dr. med. Evgeny A. Idelevich, Universitätsmedizin Greifswald - Friedrich Loeffler-Institut für Medizinische Mikrobiologie, Germany
4:25-4:50 MicrobeNet International: Building Pathogen Identification Capacity Worldwide
John R. McQuiston, Ph.D., Bacterial Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention (CDC), Atlanta/USA
4:50-5:15 Phenotypic Detection of Colistin Resistance – New Approaches
Sofia Somajo, Ph.D., Senior Lecturer in Biomedical Laboratory Science, Linnaeus University Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences, Sweden
5:15-5:40 Drug Resistant TB: Bridging the Gap between Treatment Regimens and Diagnostics
Margaretha de Vos, Ph.D., FIND, Geneva/Switzerland
5:40-6:05 Exploiting State-of-the-Art Technologies to Take Infectious Disease Diagnostics and Hygiene Control to the Next Level
Dr. Markus Kostrzewa, Senior Vice President R&D, Regulatory Affairs and Scientific Affairs, Microbiology & Diagnostics, Bruker Daltonics GmbH & Co. KG, Bremen/Germany
6:05-6:15 Panel Discussion and Q&A
Take a look on our poster list, covering a broad range of scientific and diagnostic topics that Bruker Microbiology & Diagnostics and its cooperation partners have recently worked on.